Passa al contenuto
Merck
  • Acceptability and Barriers to Use of the ASMAN Provider-Facing Electronic Platform for Peripartum Care in Public Facilities in Madhya Pradesh and Rajasthan, India: A Qualitative Study Using the Technology Acceptance Model-3.

Acceptability and Barriers to Use of the ASMAN Provider-Facing Electronic Platform for Peripartum Care in Public Facilities in Madhya Pradesh and Rajasthan, India: A Qualitative Study Using the Technology Acceptance Model-3.

International journal of environmental research and public health (2020-11-15)
Gulnoza Usmanova, Ashley Gresh, Megan A Cohen, Young-Mi Kim, Ashish Srivastava, Chandra Shekhar Joshi, Deepak Chandra Bhatt, Rachel Haws, Rajni Wadhwa, Pompy Sridhar, Nupur Bahl, Pratibha Gaikwad, Jean Anderson
ABSTRACT

The evolving field of mobile health (mHealth) is revolutionizing collection, management, and quality of clinical data in health systems. Particularly in low- and middle-income countries (LMICs), mHealth approaches for clinical decision support and record-keeping offer numerous potential advantages over paper records and in-person training and supervision. We conducted a content analysis of qualitative in-depth interviews using the Technology Acceptance Model 3 (TAM-3) to explore perspectives of providers and health managers in Madhya Pradesh and Rajasthan, India who were using the ASMAN (Alliance for Saving Mothers and Newborns) platform, a package of mHealth technologies to support management during the peripartum period. Respondents uniformly found ASMAN easy to use and felt it improved quality of care, reduced referral rates, ensured timely referral when needed, and aided reporting requirements. The TAM-3 model captured many determinants of reported respondent use behavior, including shifting workflow and job performance. However, some barriers to ASMAN digital platform use were structural and reported more often in facilities where ASMAN use was less consistent; these affect long-term impact, sustainability, and scalability of ASMAN and similar mHealth interventions. The transitioning of the program to the government, ensuring availability of dedicated funds, human resource support, and training and integration with government health information systems will ensure the sustainability of ASMAN.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Sigma-Aldrich
α-Amylase from Aspergillus oryzae, powder, ~30 U/mg
Sigma-Aldrich
Ammonium metavanadate, puriss. p.a., ACS reagent, ≥99.0% (RT)